NFE2L2 and Familial prostate cancer: Moreover, it has been shown that Z-LIG is able to reactivate nuclear factor-erythroid-2-related factor 2 (Nrf2), a key regulator of cellular antioxidant defense, by the epigenetic modification mechanism in murine prostate cancer TRAMP C1 cells [29].